+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors

Brain 123: 733-745

Hallucinations, mainly of a visual nature, are considered to affect about one-quarter of patients with Parkinson's disease. They are commonly viewed as a side-effect of antiparkinsonian treatment, but other factors may be involved. The aim of this study was to determine the phenomenology, prevalence and risk factors of hallucinations in Parkinson's disease. Two-hundred and sixteen consecutive patients fulfilling clinical criteria for Parkinson's disease were studied. Demographic and clinical variables were recorded, including motor and cognitive status, depressive symptoms and sleep-wake disturbances. Patients with and without hallucinations were compared using non-parametric tests, and logistic regression was applied to significant data. Hallucinations had been present during the previous 3 months in 39.8% of the patients, and fell into three categories: minor forms, consisting of a sensation of a presence (person), a sideways passage (commonly of an animal) or illusions were present in 25.5% of the patients (an isolated occurrence in 14.3%), formed visual hallucinations were present in 22.2% (isolated in 9.3%) and auditory hallucinations were present in 9.7% (isolated in 2.3%). Patients with minor hallucinations had a higher depression score than non-hallucinators but did not differ in other respects. Logistic regression analysis identified three factors independently predictive of formed visual hallucinations: severe cognitive disorders, daytime somnolence and a long duration of Parkinson's disease. These findings indicate that, when minor hallucinations are included, the total prevalence is much higher than previously reported. A simple side-effect of dopaminergic treatment is not sufficient to explain the occurrence of all visual hallucinations. The main risk factor in treated patients is cognitive impairment, although sleep-wake cycle disturbances, and possibly other factors related to the duration of the disease, act as cofactors.

(PDF emailed within 0-6 h: $19.90)

Accession: 010734508

Download citation: RISBibTeXText

PMID: 10734005

DOI: 10.1093/brain/123.4.733

Related references

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745. American Journal of Ophthalmology 130(2): 261-262, 2000

Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 83(10): 1019-1021, 2012

Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease. Journal of the Neurological Sciences (): -, 2016

Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. International Journal of Geriatric Psychiatry 28(6): 626-631, 2014

Prevalence, associated factors and phenomenology of psychosis in patients with Parkinson's disease. Gaceta Medica de Mexico 151(2): 169-175, 2015

New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins. Expert Review of Neurotherapeutics 7(12): 1731-1750, 2007

Risk factors for visual hallucinations in patients with Parkinson's disease. Neurological Research 37(2): 112-116, 2015

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology 69(2): 187-195, 2007

Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms. Cns Spectrums 13(3 Suppl 4): 18-25, 2008

Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study. Movement Disorders 28(6): 755-762, 2014

A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease. Neuroepidemiology 37(3-4): 222-230, 2012

Study of associated clinical variables and phenomenology of hallucinations in Parkinson's. Neurologia 21(1): 12-18, 2006

Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson's disease. Journal of Parkinson's Disease 2(3): 199-205, 2014

Social phobia in Parkinson's disease: Prevalence and risk factors. Neuropsychiatric Disease and Treatment 10(): 829-834, 2014

Anxiety disorders in Parkinson's disease: prevalence and risk factors. Movement Disorders 25(7): 838-845, 2010